Publication Details

Phase I trial of etoposide with cyclosporine as a modulator of multidrug resistance.

Yahanda AM, Alder KM, Fisher GA, Brophy NA, Halsey J, Hardy RI, Gosland MP, Lum BL, Sikic BI. J Clin Oncol. 1992; 10 (10): 1624-34

To determine the maximum-tolerated dose (MTD) of cyclosporine (CsA) infusion administered with etoposide for 3 days in patients with cancer.

PubMedID: 1403040